1. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017; 390:1550–62.
Article
2. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022; 8:30.
Article
3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87:489–99.
4. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007; 17:1211–23.
Article
5. Asvold BO, Vatten LJ, Bjoro T. Changes in the prevalence of hypothyroidism: the HUNT Study in Norway. Eur J Endocrinol. 2013; 169:613–20.
Article
6. Kwon H, Jung JH, Han KD, Park YG, Cho JH, Lee DY, et al. Prevalence and annual incidence of thyroid disease in Korea from 2006 to 2015: a nationwide population-based cohort study. Endocrinol Metab (Seoul). 2018; 33:260–7.
Article
7. Kim EH, Jeon YK, Pak K, Kim IJ, Kim SJ, Shin S, et al. Effects of thyrotropin suppression on bone health in menopausal women with total thyroidectomy. J Bone Metab. 2019; 26:31–8.
8. Xia Q, Dong S, Bian PD, Wang J, Li CJ. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma. Eur Arch Otorhinolaryngol. 2016; 273:1037–43.
Article
9. Seo GH, Chung JH. Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the Health Insurance Review and Assessment Service. Endocrinol Metab (Seoul). 2015; 30:288–96.
Article
10. Seong SC, Kim YY, Khang YH, Park JH, Kang HJ, Lee H, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017; 46:799–800.
11. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014; 99:923–31.
14. Concepcion-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, Concepcion-Urteaga LA, Paz-Ibarra J. Thyroid dysfunction and female infertility: a comprehensive review. Diabetes Metab Syndr. 2023; 17:102876.
15. Zhang S, Yang M, Li T, Yang M, Wang W, Chen Y, et al. High level of thyroid peroxidase antibodies as a detrimental risk of pregnancy outcomes in euthyroid women undergoing ART: a meta-analysis. Mol Reprod Dev. 2023; 90:218–26.
16. Lee J, Yeoh Y, Seo MJ, Lee GH, Kim CI. Estimation of dietary iodine intake of Koreans through a Total Diet Study (TDS). Korean J Community Nutr. 2021; 26:48–55.
17. Ko YM, Kwon YS, Park YK. An iodine database establishment and iodine intake in Korean adults: based on the 1998-2014 Korea National Health and Nutrition Examination Survey. J Nutr Health. 2017; 50:624–44.
Article
18. Jung KY, Kim H, Choi HS, An JH, Cho SW, Kim HJ, et al. Clinical factors predicting the successful discontinuation of hormone replacement therapy in patients diagnosed with primary hypothyroidism. PLoS One. 2020; 15:e0233596.
Article
19. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005; 165:2460–6.
20. Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2013; 98:533–40.
21. Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid. 2018; 28:1101–10.
Article
22. Yang MH, Yang FY, Lee DD. Thyroid disease as a risk factor for cerebrovascular disease. J Stroke Cerebrovasc Dis. 2015; 24:912–20.
23. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007; 14:e1–26.
24. Ye Y, Wang Y, Li S, Guo J, Ding L, Liu M. Association of hypothyroidism and the risk of cognitive dysfunction: a meta-analysis. J Clin Med. 2022; 11:6726.
25. Akintola AA, Jansen SW, van Bodegom D, van der Grond J, Westendorp RG, de Craen AJ, et al. Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci. 2015; 7:150.
26. Wu Y, Pei Y, Wang F, Xu D, Cui W. Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies. Sci Rep. 2016; 6:31975.